Antibacterial activity of ethanolic extracts of phyllanthus amarus against extended spectrum βlactamase producing escherichia coli isolated from stool samples of HIV sero-positive patients with or without diarrhoea

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 6, 2010, Pages 402-407

  Akinjogunla, O J ^a   Eghafona, N O ^b   Enabulele, I O ^b   Mboto, C I ^c   Ogbemudia, F O ^a  

^a UNIVERSITY OF UYO   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

^c UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Beta lactamase; Cephalosporin; Escherichia coli; HIV; Phyllanthus amarus; Susceptibility

Indexed keywords

ALKALOID; AMPICILLIN; ANTHRAQUINONE DERIVATIVE; ANTIINFECTIVE AGENT; CARDIAC GLYCOSIDE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLAVONOID; GENTAMICIN; OFLOXACIN; PHYLLANTHUS AMARUS EXTRACT; SAPONIN; TANNIN DERIVATIVE; TERPENE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DIFFUSION; DRUG EFFICACY; DRUG ISOLATION; ESCHERICHIA COLI; FECES ANALYSIS; GASTROENTERITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PHYTOCHEMISTRY; PLANT LEAF; PLANT ROOT;

EID: 77954681880     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abu-Zaida ME, Mashaly IA, AbdEl-Monem M, Torky M (2008). Economic potentials of some aquatic plants growing in North East Nile delta, Egypt. J. Appl. Sci., 8(1): 1395-1405.
2. Adebayo-Tayo BC, Adegoke AA (2008). Phytochemical and microbial screening of herbal remedies in Akwa Ibom State, South Southern Nigeria. J. Med. Plants Res., 2(11): 306-310.
3. Akinjobi CO, Anyanwu BN, Onyeze GOC (2004). Antibacterial Activities and Preliminary Phytochemical screening of four medicinal plants. J. Appl. Sci., 7(3): 4328-4338.
4. Akinjogunla OJ, Adegoke AA (2009b). Sero-prevalence of human immunodeficiency virus (HIV) 1 and 2 infections in Uyo metropolis, Akwa Ibom State. Scientific Research and Essays 4(6): 590-593.
5. Akinjogunla OJ, Adegoke AA, Udokang IP, Adebayo-tayo BC (2009a). Antimicrobial potential of Nymphaea lotus (Nymphaeaceae) against wound pathogens. J. Med. Plants Res., 3(3): 138-141.
6. Bauer AW, Kirby WM, Sherris JC (1996). Antibiotic susceptibility testing by a standard single disc method. Am. J. Clin. Pathol. 451: 493-496.
7. Bharatiya VB (1992). Selected Medicinal Plants of India. Bombany Tafa Press, pp. 235-237.
8. Bronson JJ, Barrett JF (2001). Quinolone, Everninomycin, Glycylcycline, Carbapenem, Lipopeptide and Cephem Antibacterial in Clinical Development. Curr. Med. Chem., 8: 1775-1793.
9. Cheesbrough M (2004). District Laboratory Practice in Tropical Countries (Part II). Cambridge University, pp. 50-120
10. th Edition). Cambridge University Press. London. p. 217.
11. Cushnie TP, Lamb AJ (2005). Antimicrobial activities of flavonoids. Int. J. Antimicrobial Agents, 26: 343.
12. Ebana RUB, Madunagu BE, Ekpe ED (2005). Microbiological exploitation of cardiac glycosides and alkaloids from Garcinia kola, Borreli ocymoides,Kola nitida Citrus aurantifolia. J. Appl. Bacteriol., 71: 398-401.
13. Evans WC (1989). Trease and Evans Pharmacognosy. 13th Edition, Bailere Tyndall, London. pp. 101-104.
14. Fawole MO, Oso BA (1988). Laboratory Manual for Microbiology (Ist Edition), Spectrum Book Ltd, Ibadan. pp. 22-45.
15. Georges AJ, Georges-courboj MC (1990). Epidemiology of HIV infections in Africa Rev. Prat., 40(23): 2131-213.
16. Livermore DM (1995). Beta-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev., 8: 557-584.
17. Nataro JP, Kaper JB, Robins-Browne R (1987). Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Paediatric Infect. Dis. J., 6: 829-831.
18. Olowusulu AK, Ibrahim YKE (2006). Studies on the antimicrobial screening of aqueous extracts of five plants used in Folk medicine in Nigeria. West Afr. J. Biol. Sci., 3(5): 21-26.
19. Oluwafemi F, Debiri F (2008). Antimicrobial Effect of Phyllanthus amarus and Parquetina nigrescens on Salmonella typhi. Afr. J. Biomed. Res., 11: 215-219.
20. Pennap GRI, Makut MD, Gyar SD (2006). Sero-prevalence of HIV/AIDS in Keffi and Environs. Niger. J. Microbiol., 20(3): 1114-1146.
21. Piddock LJV, Wise R (1989). Mechanisms of resistance to quinolones and clinical perspectives. J. Antimicrobial Chemother., 23(4): 475- 480.
22. th edition pp. 746-753.
23. Sanders CC, Sanders WE (1987). Clinical importance of inducible beta- lactamases in gramnegative bacteria. Euro. J. Clin. Microbiol., 6: 435-438.
24. Shah PM. (2005). The need for new therapeutic agents: What is in the pipeline? Clin. Microbiol. Inf., 11: 36-42.
25. Smith SI, Aboaba, OO, Odeigha P (2003). Plasmids profiles E coli from apparently healthy animals. Afr.J. Biotechnol. 2(9): 322-324.
26. Sofowora A (1986). Medicinal plant and traditional medicine in Africa II, John Wiley Chiechester. p. 178.
27. nd edition), published by Spectrum Books Limited, Ibadan, Nigeria. pp. 130.
28. Talaro K, Talaro A (1996). Acquired Immunodeficiency Syndromes, Foundation in Microbiology pp. 787-798
29. Tsuchiya HMS, Miyazaki T, Fujiwara S (1996). Comparative study on the antibacterial activity of bacterial flavones against methicillin resistant Staphylococcus aureus. J. Ethnophamacol., 50: 27-34.
30. Yah SC, Eghafona NO, Enabulele IO (2006). Ampicillin Usage and Ampicillin Resistant (Ampr) Plasmids Mediated Escherichia Coli Isolated from Diarrheagenic Patients Attending Some Teaching Hospital in Nigeria. Shiraz E-Med. J., 7(4): 1-12.